Review



human trim33  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    Addgene inc human trim33
    <t>TRIM33</t> is phosphorylated by RSK at S1119. A , HEK293 cells were transfected with HA-tagged TRIM33, serum-starved overnight, and stimulated for 10 or 20 min with fetal bovine serum (FBS; 10%), EGF (25 ng/ml), insulin (100 nM), or PMA (50 ng/ml). Immunoprecipitated TRIM33 was then assayed for phosphorylation with a phospho-motif antibody that recognizes the RxxS∗/T∗ consensus motif. B , same as in ( A ), except cells were pretreated with PD184352 (10 μM) or BI-D1870 (10 μM) for 30 min prior to PMA stimulation. C , as in ( A ), except cells were transfected with HA-tagged TRIM33 WT or the S1119A unphosphorylable mutant. D , detection of phospho-RxxS∗/T∗ in TRIM33-WT and -S1119A in WT and RSK-DKO HeLa cells. Cells transfected with the HA-tagged TRIM33 constructs were stimulated for 30 min with PMA prior to HA immunoprecipitation. PMA, phorbol 12-myristate 13-acetate; RSK, ribosomal S6 kinase.
    Human Trim33, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human trim33/product/Addgene inc
    Average 93 stars, based on 3 article reviews
    human trim33 - by Bioz Stars, 2026-06
    93/100 stars

    Images

    1) Product Images from "Identification of RSK substrates using an analog-sensitive kinase approach"

    Article Title: Identification of RSK substrates using an analog-sensitive kinase approach

    Journal: The Journal of Biological Chemistry

    doi: 10.1016/j.jbc.2024.105739

    TRIM33 is phosphorylated by RSK at S1119. A , HEK293 cells were transfected with HA-tagged TRIM33, serum-starved overnight, and stimulated for 10 or 20 min with fetal bovine serum (FBS; 10%), EGF (25 ng/ml), insulin (100 nM), or PMA (50 ng/ml). Immunoprecipitated TRIM33 was then assayed for phosphorylation with a phospho-motif antibody that recognizes the RxxS∗/T∗ consensus motif. B , same as in ( A ), except cells were pretreated with PD184352 (10 μM) or BI-D1870 (10 μM) for 30 min prior to PMA stimulation. C , as in ( A ), except cells were transfected with HA-tagged TRIM33 WT or the S1119A unphosphorylable mutant. D , detection of phospho-RxxS∗/T∗ in TRIM33-WT and -S1119A in WT and RSK-DKO HeLa cells. Cells transfected with the HA-tagged TRIM33 constructs were stimulated for 30 min with PMA prior to HA immunoprecipitation. PMA, phorbol 12-myristate 13-acetate; RSK, ribosomal S6 kinase.
    Figure Legend Snippet: TRIM33 is phosphorylated by RSK at S1119. A , HEK293 cells were transfected with HA-tagged TRIM33, serum-starved overnight, and stimulated for 10 or 20 min with fetal bovine serum (FBS; 10%), EGF (25 ng/ml), insulin (100 nM), or PMA (50 ng/ml). Immunoprecipitated TRIM33 was then assayed for phosphorylation with a phospho-motif antibody that recognizes the RxxS∗/T∗ consensus motif. B , same as in ( A ), except cells were pretreated with PD184352 (10 μM) or BI-D1870 (10 μM) for 30 min prior to PMA stimulation. C , as in ( A ), except cells were transfected with HA-tagged TRIM33 WT or the S1119A unphosphorylable mutant. D , detection of phospho-RxxS∗/T∗ in TRIM33-WT and -S1119A in WT and RSK-DKO HeLa cells. Cells transfected with the HA-tagged TRIM33 constructs were stimulated for 30 min with PMA prior to HA immunoprecipitation. PMA, phorbol 12-myristate 13-acetate; RSK, ribosomal S6 kinase.

    Techniques Used: Transfection, Immunoprecipitation, Phospho-proteomics, Mutagenesis, Construct



    Similar Products

    93
    Addgene inc human trim33
    <t>TRIM33</t> is phosphorylated by RSK at S1119. A , HEK293 cells were transfected with HA-tagged TRIM33, serum-starved overnight, and stimulated for 10 or 20 min with fetal bovine serum (FBS; 10%), EGF (25 ng/ml), insulin (100 nM), or PMA (50 ng/ml). Immunoprecipitated TRIM33 was then assayed for phosphorylation with a phospho-motif antibody that recognizes the RxxS∗/T∗ consensus motif. B , same as in ( A ), except cells were pretreated with PD184352 (10 μM) or BI-D1870 (10 μM) for 30 min prior to PMA stimulation. C , as in ( A ), except cells were transfected with HA-tagged TRIM33 WT or the S1119A unphosphorylable mutant. D , detection of phospho-RxxS∗/T∗ in TRIM33-WT and -S1119A in WT and RSK-DKO HeLa cells. Cells transfected with the HA-tagged TRIM33 constructs were stimulated for 30 min with PMA prior to HA immunoprecipitation. PMA, phorbol 12-myristate 13-acetate; RSK, ribosomal S6 kinase.
    Human Trim33, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human trim33/product/Addgene inc
    Average 93 stars, based on 1 article reviews
    human trim33 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    GenScript corporation cdna encoding human trim33
    <t>TRIM33</t> is phosphorylated by RSK at S1119. A , HEK293 cells were transfected with HA-tagged TRIM33, serum-starved overnight, and stimulated for 10 or 20 min with fetal bovine serum (FBS; 10%), EGF (25 ng/ml), insulin (100 nM), or PMA (50 ng/ml). Immunoprecipitated TRIM33 was then assayed for phosphorylation with a phospho-motif antibody that recognizes the RxxS∗/T∗ consensus motif. B , same as in ( A ), except cells were pretreated with PD184352 (10 μM) or BI-D1870 (10 μM) for 30 min prior to PMA stimulation. C , as in ( A ), except cells were transfected with HA-tagged TRIM33 WT or the S1119A unphosphorylable mutant. D , detection of phospho-RxxS∗/T∗ in TRIM33-WT and -S1119A in WT and RSK-DKO HeLa cells. Cells transfected with the HA-tagged TRIM33 constructs were stimulated for 30 min with PMA prior to HA immunoprecipitation. PMA, phorbol 12-myristate 13-acetate; RSK, ribosomal S6 kinase.
    Cdna Encoding Human Trim33, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cdna encoding human trim33/product/GenScript corporation
    Average 90 stars, based on 1 article reviews
    cdna encoding human trim33 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    93
    Proteintech rabbit antibody against human trim33
    The expression of <t>TRIM33</t> in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.
    Rabbit Antibody Against Human Trim33, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit antibody against human trim33/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit antibody against human trim33 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    OriGene shtif1γ
    The expression of <t>TRIM33</t> in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.
    Shtif1γ, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/shtif1γ/product/OriGene
    Average 90 stars, based on 1 article reviews
    shtif1γ - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    OriGene recombinant tif1 protein
    The expression of <t>TRIM33</t> in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.
    Recombinant Tif1 Protein, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant tif1 protein/product/OriGene
    Average 90 stars, based on 1 article reviews
    recombinant tif1 protein - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    OriGene tif1 gamma (trim33) (nm_015906) human recombinant protein
    The expression of <t>TRIM33</t> in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.
    Tif1 Gamma (Trim33) (Nm 015906) Human Recombinant Protein, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tif1 gamma (trim33) (nm_015906) human recombinant protein/product/OriGene
    Average 90 stars, based on 1 article reviews
    tif1 gamma (trim33) (nm_015906) human recombinant protein - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    OriGene trim33 origene cat
    The expression of <t>TRIM33</t> in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.
    Trim33 Origene Cat, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/trim33 origene cat/product/OriGene
    Average 90 stars, based on 1 article reviews
    trim33 origene cat - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    OriGene recombinant full length human tif1 gamma trim33 protein
    The expression of <t>TRIM33</t> in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.
    Recombinant Full Length Human Tif1 Gamma Trim33 Protein, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/recombinant full length human tif1 gamma trim33 protein/product/OriGene
    Average 90 stars, based on 1 article reviews
    recombinant full length human tif1 gamma trim33 protein - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    OriGene tif1 gamma (trim33) (nm_015906) human tagged orf clone
    The expression of <t>TRIM33</t> in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.
    Tif1 Gamma (Trim33) (Nm 015906) Human Tagged Orf Clone, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tif1 gamma (trim33) (nm_015906) human tagged orf clone/product/OriGene
    Average 90 stars, based on 1 article reviews
    tif1 gamma (trim33) (nm_015906) human tagged orf clone - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    TRIM33 is phosphorylated by RSK at S1119. A , HEK293 cells were transfected with HA-tagged TRIM33, serum-starved overnight, and stimulated for 10 or 20 min with fetal bovine serum (FBS; 10%), EGF (25 ng/ml), insulin (100 nM), or PMA (50 ng/ml). Immunoprecipitated TRIM33 was then assayed for phosphorylation with a phospho-motif antibody that recognizes the RxxS∗/T∗ consensus motif. B , same as in ( A ), except cells were pretreated with PD184352 (10 μM) or BI-D1870 (10 μM) for 30 min prior to PMA stimulation. C , as in ( A ), except cells were transfected with HA-tagged TRIM33 WT or the S1119A unphosphorylable mutant. D , detection of phospho-RxxS∗/T∗ in TRIM33-WT and -S1119A in WT and RSK-DKO HeLa cells. Cells transfected with the HA-tagged TRIM33 constructs were stimulated for 30 min with PMA prior to HA immunoprecipitation. PMA, phorbol 12-myristate 13-acetate; RSK, ribosomal S6 kinase.

    Journal: The Journal of Biological Chemistry

    Article Title: Identification of RSK substrates using an analog-sensitive kinase approach

    doi: 10.1016/j.jbc.2024.105739

    Figure Lengend Snippet: TRIM33 is phosphorylated by RSK at S1119. A , HEK293 cells were transfected with HA-tagged TRIM33, serum-starved overnight, and stimulated for 10 or 20 min with fetal bovine serum (FBS; 10%), EGF (25 ng/ml), insulin (100 nM), or PMA (50 ng/ml). Immunoprecipitated TRIM33 was then assayed for phosphorylation with a phospho-motif antibody that recognizes the RxxS∗/T∗ consensus motif. B , same as in ( A ), except cells were pretreated with PD184352 (10 μM) or BI-D1870 (10 μM) for 30 min prior to PMA stimulation. C , as in ( A ), except cells were transfected with HA-tagged TRIM33 WT or the S1119A unphosphorylable mutant. D , detection of phospho-RxxS∗/T∗ in TRIM33-WT and -S1119A in WT and RSK-DKO HeLa cells. Cells transfected with the HA-tagged TRIM33 constructs were stimulated for 30 min with PMA prior to HA immunoprecipitation. PMA, phorbol 12-myristate 13-acetate; RSK, ribosomal S6 kinase.

    Article Snippet: The original plasmid encoding human TRIM33 (pCS2-FLAG-hEcto/Tif1g) was obtained from Dr Stefano Piccolo through Addgene (#20902).

    Techniques: Transfection, Immunoprecipitation, Phospho-proteomics, Mutagenesis, Construct

    The expression of TRIM33 in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Downregulation of TRIM33 Promotes Survival and Epithelial–Mesenchymal Transition in Gastric Cancer

    doi: 10.1177/15330338221114505

    Figure Lengend Snippet: The expression of TRIM33 in pan-cancer, and association between TRIM33 expression and the survival of patients with GC. (A) TRIM33 expression in 31 tumors from TCGA database. Red bars represent tumor samples, blue bars represent normal tissue samples. (B) OS, FPS, and PPS curves in patients with GC. (C) Survival curves of different pTNM stages in patients with GC. (D) Survival curves of different pT stages in patients with GC. * P < .05, ** P < .01, *** P < .001 versus normal tissue samples.

    Article Snippet: The rabbit antibody against human TRIM33 (Cat No. 55374-1-AP) was purchased from ProteinTech; rabbit antibodies against human phospho-Smad2 (p-Smad2; #18338), Smad2 (#5339), Smad3 (#9523), Smad4 (#46535), vimentin (#5741), N-Cadherin (#13116), E-Cadherin (#3195), and β-actin (#5125), as well as a horseradish peroxidase-linked goat anti-rabbit antibody (#7074), were purchased from Cell Signaling Technology.

    Techniques: Expressing

    Knockdown of TRIM33 promoted the proliferation of BGC-823 and SGC-7901 cells. (A&B) Western blot analysis of TRIM33 expression in GES, BGC-823, MGC-803, and SGC-7901 cell lines. (C&D) Western blot analysis of TRIM33 protein expression in cells transfected with si-TRIM33 encoding plasmids. (E) CCK8 assays were used to measure BGC-823 and SGC-7901 cell viability in the control and si-TRIM33-transfected group; the viability of the si-TRIM33 transfection groups was enhanced. (F&G) EdU assays were used to evaluate proliferation in the control and si-TRIM33 transfection groups in BGC-823 cells; the percentage of EdU-positive cells in the si-TRIM33 group was significantly greater than in the control group. * P < .05, ** P < .01; ns, non-significant.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Downregulation of TRIM33 Promotes Survival and Epithelial–Mesenchymal Transition in Gastric Cancer

    doi: 10.1177/15330338221114505

    Figure Lengend Snippet: Knockdown of TRIM33 promoted the proliferation of BGC-823 and SGC-7901 cells. (A&B) Western blot analysis of TRIM33 expression in GES, BGC-823, MGC-803, and SGC-7901 cell lines. (C&D) Western blot analysis of TRIM33 protein expression in cells transfected with si-TRIM33 encoding plasmids. (E) CCK8 assays were used to measure BGC-823 and SGC-7901 cell viability in the control and si-TRIM33-transfected group; the viability of the si-TRIM33 transfection groups was enhanced. (F&G) EdU assays were used to evaluate proliferation in the control and si-TRIM33 transfection groups in BGC-823 cells; the percentage of EdU-positive cells in the si-TRIM33 group was significantly greater than in the control group. * P < .05, ** P < .01; ns, non-significant.

    Article Snippet: The rabbit antibody against human TRIM33 (Cat No. 55374-1-AP) was purchased from ProteinTech; rabbit antibodies against human phospho-Smad2 (p-Smad2; #18338), Smad2 (#5339), Smad3 (#9523), Smad4 (#46535), vimentin (#5741), N-Cadherin (#13116), E-Cadherin (#3195), and β-actin (#5125), as well as a horseradish peroxidase-linked goat anti-rabbit antibody (#7074), were purchased from Cell Signaling Technology.

    Techniques: Knockdown, Western Blot, Expressing, Transfection, Control

    Downregulation of TRIM33 enhanced colony formation and migratory ability. (A&B) Downregulation of TRIM33 promoted colony formation in BGC-823 and SGC-7901 cells. (C&D) After 24 h, the number of cells passing through the Transwell membrane was higher in the si-TRIM33 group than in the control group (×100 magnification, corresponding to a scale of 200 μm). (E&F) After 12, 24, 48, 72, 96, 120, and 144 h, the width of the residual scratch was narrower in the si-TRIM33 group than in the control group (×100 magnification, corresponding to a scale of 200 μm). * P < .05, ** P < .01.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Downregulation of TRIM33 Promotes Survival and Epithelial–Mesenchymal Transition in Gastric Cancer

    doi: 10.1177/15330338221114505

    Figure Lengend Snippet: Downregulation of TRIM33 enhanced colony formation and migratory ability. (A&B) Downregulation of TRIM33 promoted colony formation in BGC-823 and SGC-7901 cells. (C&D) After 24 h, the number of cells passing through the Transwell membrane was higher in the si-TRIM33 group than in the control group (×100 magnification, corresponding to a scale of 200 μm). (E&F) After 12, 24, 48, 72, 96, 120, and 144 h, the width of the residual scratch was narrower in the si-TRIM33 group than in the control group (×100 magnification, corresponding to a scale of 200 μm). * P < .05, ** P < .01.

    Article Snippet: The rabbit antibody against human TRIM33 (Cat No. 55374-1-AP) was purchased from ProteinTech; rabbit antibodies against human phospho-Smad2 (p-Smad2; #18338), Smad2 (#5339), Smad3 (#9523), Smad4 (#46535), vimentin (#5741), N-Cadherin (#13116), E-Cadherin (#3195), and β-actin (#5125), as well as a horseradish peroxidase-linked goat anti-rabbit antibody (#7074), were purchased from Cell Signaling Technology.

    Techniques: Membrane, Control

    Knockdown of TRIM33 upregulated TGF-β expression. (A) ELISA analysis of TGF-β expression in the si-TRIM33 and control groups identified that knockdown of TRIM33 upregulated TGF-β expression, suggesting activation of the TGF-β signaling pathway. (B&C) Western blot analysis of the expression of proteins in the TGF-β signaling pathway in control, si-NC, and si-TRIM33 cells. Expression of p-Smad2 (Ser465/467), Smad2, Smad3, Smad4, vimentin, and N-Cadherin was upregulated, and E-Cadherin expression was downregulated, in si-TRIM33 cells. * P < .05, ** P < .01.

    Journal: Technology in Cancer Research & Treatment

    Article Title: Downregulation of TRIM33 Promotes Survival and Epithelial–Mesenchymal Transition in Gastric Cancer

    doi: 10.1177/15330338221114505

    Figure Lengend Snippet: Knockdown of TRIM33 upregulated TGF-β expression. (A) ELISA analysis of TGF-β expression in the si-TRIM33 and control groups identified that knockdown of TRIM33 upregulated TGF-β expression, suggesting activation of the TGF-β signaling pathway. (B&C) Western blot analysis of the expression of proteins in the TGF-β signaling pathway in control, si-NC, and si-TRIM33 cells. Expression of p-Smad2 (Ser465/467), Smad2, Smad3, Smad4, vimentin, and N-Cadherin was upregulated, and E-Cadherin expression was downregulated, in si-TRIM33 cells. * P < .05, ** P < .01.

    Article Snippet: The rabbit antibody against human TRIM33 (Cat No. 55374-1-AP) was purchased from ProteinTech; rabbit antibodies against human phospho-Smad2 (p-Smad2; #18338), Smad2 (#5339), Smad3 (#9523), Smad4 (#46535), vimentin (#5741), N-Cadherin (#13116), E-Cadherin (#3195), and β-actin (#5125), as well as a horseradish peroxidase-linked goat anti-rabbit antibody (#7074), were purchased from Cell Signaling Technology.

    Techniques: Knockdown, Expressing, Enzyme-linked Immunosorbent Assay, Control, Activation Assay, Western Blot

    Knockdown of TRIM33 promoted GC growth in vivo. (A) The xenograft model of TRIM33-knockdown revealed that tumors were significantly larger in si-TRIM33 animals than in controls. (B&C) Immunohistochemical analysis identified that the protein levels of TRIM33, p-Smad2 (Ser465/467), Smad2, Smad3, Smad4, vimentin, and N-Cadherin were increased, and levels of E-Cadherin were decreased, in xenograft tumors from the si-TRIM33 group (×100 and ×400 magnification in left- and right-hand side images, corresponding to a scale of 200 and 50 μm, respectively).

    Journal: Technology in Cancer Research & Treatment

    Article Title: Downregulation of TRIM33 Promotes Survival and Epithelial–Mesenchymal Transition in Gastric Cancer

    doi: 10.1177/15330338221114505

    Figure Lengend Snippet: Knockdown of TRIM33 promoted GC growth in vivo. (A) The xenograft model of TRIM33-knockdown revealed that tumors were significantly larger in si-TRIM33 animals than in controls. (B&C) Immunohistochemical analysis identified that the protein levels of TRIM33, p-Smad2 (Ser465/467), Smad2, Smad3, Smad4, vimentin, and N-Cadherin were increased, and levels of E-Cadherin were decreased, in xenograft tumors from the si-TRIM33 group (×100 and ×400 magnification in left- and right-hand side images, corresponding to a scale of 200 and 50 μm, respectively).

    Article Snippet: The rabbit antibody against human TRIM33 (Cat No. 55374-1-AP) was purchased from ProteinTech; rabbit antibodies against human phospho-Smad2 (p-Smad2; #18338), Smad2 (#5339), Smad3 (#9523), Smad4 (#46535), vimentin (#5741), N-Cadherin (#13116), E-Cadherin (#3195), and β-actin (#5125), as well as a horseradish peroxidase-linked goat anti-rabbit antibody (#7074), were purchased from Cell Signaling Technology.

    Techniques: Knockdown, In Vivo, Immunohistochemical staining